7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann
The European Hematology Association (EHA) 2025 events bring together global experts to explore the latest advances in hematology. This year features two major gatherings: the EHA Research Conference (March 17–20 in Málaga, Spain), focusing on transcriptional control and chromatin in hematopoiesis, and the 30th EHA Annual Congress (June 12–15 in Milan, Italy), a hybrid event showcasing cutting-edge research, clinical updates, and educational sessions.
EHA 2025 offers a unique platform for knowledge exchange, collaboration, and innovation in blood disorders and research.
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared following posts from EHA 2025 on X:
1. “The best way to learn is from and with different generations.”
2. “Friends make medicine, science and life better, better together”
3. “Amazing session at EHA2025 with Coleman Lindsley and Mike Spencer Chapman chaired by Anna Sureda on
– Donor selection in families with recurreny myeloid mutations / Donor clonal hematopoiesis and recipient outcomes after transplantation
– Philogenetics of donor derived hematopoiesis”
4. “Fresh start with Clonal Hematopoiesis at last day of EHA2025 with Mikko Myllymäki”
5. “Excellent presentation by Carmelo Gurnari on the clinico genomic features of therapy-related myeloid neoplasm in EHA2025.”
6. “Fascinating European Hematology Association and The EBMT session at EHA2025 chaired by
Anna Sureda and Konstanze Döhner covering
New strategies for mismatched SCT (advances in donor selection and immunosuppression) by F Ciceri
The role of CAR-T as bridging to SCT (CAR-T vs SCT, or CAR-T and SCT?) by MariSubklewe
Outpatient CAR-T by Alexandra Martínez-Roca”
7. “Amazing Young EHA session at EHA2025 on critical appraisal of trialsSurrogates by Come Bommier.
Trial interpretation Eddie Cliff
And much more giving food for brain.”
Find more posts featuring EHA 2025 on Hemostasis Today.
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation